Perceptive Capital Solutions Corp

PCSC Nasdaq CIK: 0002017526

Company Information

Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation Cayman Islands
Business Address 51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY, 10003
Mailing Address 51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY, 10003
Phone 212-284-2300
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 11, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 11, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) January 13, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) January 13, 2026 View on SEC

Annual Reports

10-K March 12, 2026
  • Secured a definitive business combination agreement with Freenome, a leading AI genomics company focused on early cancer detection, on January 2, 2024.
  • Successfully completed its IPO on June 13, 2023, raising $86.25 million, which is held in a Trust Account.
View Analysis

Related Companies

Companies in the same industry (SIC: 8071)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.